# Yakir Segev

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yakir-segev/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,055 |
| Field | Endometrial and Cervical Cancer Treatments |
| h-index | 22 |
| i10-index | 40 |
| Last Known Institution | Carmel Medical Center |
| OpenAlex ID | https://openalex.org/A5036559574 |
| ORCID iD | 0000-0002-3483-5845 |
| Works | 139 |

## Researcher papers

- [Dynamic Nanoparticle-Based Flexible Sensors: Diagnosis of Ovarian Carcinoma from Exhaled Breath](https://scholariq.org/papers/dynamic-nanoparticle-based-flexible-sensors-diagnosis-of-ovarian-carcinoma-from/)
- [Low-grade serous ovarian cancer: A review](https://scholariq.org/papers/low-grade-serous-ovarian-cancer-a-review/)
- [Uterine serous carcinoma](https://scholariq.org/papers/uterine-serous-carcinoma/)
- [The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study](https://scholariq.org/papers/the-incidence-of-endometrial-cancer-in-women-with-brca1-and-brca2-mutations-an/)
- [The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer](https://scholariq.org/papers/the-impacts-of-neoadjuvant-chemotherapy-and-of-debulking-surgery-on-survival/)
- [Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial](https://scholariq.org/papers/overall-survival-in-patients-with-endometrial-cancer-treated-with-dostarlimab/)
- [The effect of statins on risk and survival of gynecological malignancies](https://scholariq.org/papers/the-effect-of-statins-on-risk-and-survival-of-gynecological-malignancies/)
- [Endometrial carcinosarcoma](https://scholariq.org/papers/endometrial-carcinosarcoma/)
- [BRCA germline mutations in women with uterine serous carcinoma--still a debate.](https://scholariq.org/papers/brca-germline-mutations-in-women-with-uterine-serous-carcinoma-still-a-debate/)
- [A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer](https://scholariq.org/papers/a-phase-1-2a-dose-escalation-safety-pharmacokinetic-and-preliminary-efficacy/)
- [Postoperative pain following intraoperative acupuncture: a randomized‑controlled study](https://scholariq.org/papers/postoperative-pain-following-intraoperative-acupuncture-a-randomized-controlled/)

## Researcher topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [Carmel Medical Center](https://scholariq.org/institutions/carmel-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.